Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer.
Goubet AG, Lordello L, Alves Costa Silva C, Peguillet I, Gazzano M, Mbogning-Fonkou MD, Thelemaque C, Lebacle C, Thibault C, Audenet F, Pignot G, Gravis G, Helissey C, Campedel L, Roupret M, Xylinas E, Ouzaid I, Dubuisson A, Mazzenga M, Flament C, Ly P, Marty V, Signolle N, Sauvat A, Sbarrato T, Filahi M, Davin C, Haddad G, Bou Khalil J, Bleriot C, Danlos FX, Dunsmore G, Mulder K, Silvin A, Raoult T, Archambaud B, Belhechmi S, Gomperts Boneca I, Cayet N, Moya-Nilges M, Mallet A, Daillere R, Rouleau E, Radulescu C, Allory Y, Fieschi J, Rouanne M, Ginhoux F, Le Teuff G, Derosa L, Marabelle A, Van Dorp J, Van Dijk N, Van Der Heijden MS, Besse B, Andre F, Merad M, Kroemer G, Scoazec JY, Zitvogel L, Loriot Y. Goubet AG, et al. Among authors: andre f. Cancer Discov. 2022 Oct 5;12(10):2280-2307. doi: 10.1158/2159-8290.CD-22-0201. Cancer Discov. 2022. PMID: 35929803
Malignant effusions and immunogenic tumour-derived exosomes.
Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, Pomel C, Lhomme C, Escudier B, Le Chevalier T, Tursz T, Amigorena S, Raposo G, Angevin E, Zitvogel L. Andre F, et al. Lancet. 2002 Jul 27;360(9329):295-305. doi: 10.1016/S0140-6736(02)09552-1. Lancet. 2002. PMID: 12147373
Exosomes for immunotherapy of cancer.
Chaput N, Schartz NE, Andre F, Zitvogel L. Chaput N, et al. Among authors: andre f. Adv Exp Med Biol. 2003;532:215-21. doi: 10.1007/978-1-4615-0081-0_17. Adv Exp Med Biol. 2003. PMID: 12908560 Review.
[Exosomes and anti-tumour immunotherapy].
Chaput N, Andre F, Schartz NE, Flament C, Angevin E, Escudier B, Zitvogel L. Chaput N, et al. Among authors: andre f. Bull Cancer. 2003 Aug-Sep;90(8-9):695-8. Bull Cancer. 2003. PMID: 14609758 Free article. Clinical Trial. French.
Exosome-based immunotherapy.
Chaput N, Taïeb J, Schartz NE, André F, Angevin E, Zitvogel L. Chaput N, et al. Among authors: andre f. Cancer Immunol Immunother. 2004 Mar;53(3):234-9. doi: 10.1007/s00262-003-0472-x. Epub 2004 Jan 16. Cancer Immunol Immunother. 2004. PMID: 14727085 Free PMC article. Review.
Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection.
Chaput N, Schartz NE, André F, Taïeb J, Novault S, Bonnaventure P, Aubert N, Bernard J, Lemonnier F, Merad M, Adema G, Adams M, Ferrantini M, Carpentier AF, Escudier B, Tursz T, Angevin E, Zitvogel L. Chaput N, et al. Among authors: andre f. J Immunol. 2004 Feb 15;172(4):2137-46. doi: 10.4049/jimmunol.172.4.2137. J Immunol. 2004. PMID: 14764679
The potential of exosomes in immunotherapy.
Chaput N, Taïeb J, André F, Zitvogel L. Chaput N, et al. Among authors: andre f. Expert Opin Biol Ther. 2005 Jun;5(6):737-47. doi: 10.1517/14712598.5.6.737. Expert Opin Biol Ther. 2005. PMID: 15952905 Review.
The potential of exosomes in immunotherapy of cancer.
Chaput N, Taïeb J, Schartz N, Flament C, Novault S, André F, Zitvogel L. Chaput N, et al. Among authors: andre f. Blood Cells Mol Dis. 2005 Sep-Oct;35(2):111-5. doi: 10.1016/j.bcmd.2005.05.009. Blood Cells Mol Dis. 2005. PMID: 16027014 Review.
1,103 results